News, Announcements and Expert Commentary from Inova

Posts Tagged ‘research’

FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

NPR Visits Inova to Document Infant-Health Research Study

nurse swabbing a newborn baby

Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…

Read More

For babies born by Caesarean section, can a simple swab reduce rates of obesity, asthma and allergies?

newborn grasping adult finger

Inova clinical trial investigates outcomes of exposing newborns to mother’s microbes While Caesarean section (CS) delivery can be lifesaving for both new mothers and their babies, children born by CS have an approximately 50 percent increased risk of childhood obesity, along with asthma and allergies. There is a marked difference between the microbiomes, the community…

Read More

Inova cardiac researchers publish JAMA article on use of intensive lipid-lowering drugs

The question over who should use cholesterol reducing medication is a hotly debated topic among physicians. Researchers at Inova just published an analysis in the current edition of the Journal of the American Medical Association (JAMA) providing foundational findings that will help change the understanding of when and how to use intensive lipid-lowering therapy to…

Read More

The Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors

inova logo

Washington, DC —The Society for Women’s Health Research (SWHR) announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women…

Read More

Research Breakthroughs: Advances in Breast Cancer Diagnosis & Treatment

Mary J. Wilkinson, MD, is a medical oncologist at the Inova Schar Cancer Institute. She is board- certified in medical oncology, internal medicine and hematology and has a special interest in breast cancer. A breast cancer diagnosis is always unwelcome news, but new advances in detection and treatment are leading to improvements in cancer care…

Read More

Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization

inova logo

Falls Church, VA —  Inova announced today that Mickey Y. Kim, MD, MBA, has been named Senior Vice President of Research and Commercialization. In this role, Dr. Kim will work with Inova’s institute leaders to establish Inova’s research priorities, manage its portfolio, work collaboratively with Inova’s external partners, and drive the commercialization of research. “As…

Read More

UVA, Inova award research seed funding grants to joint research teams

inova logo

The Inova Health System (Inova) and the University of Virginia (UVA) announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects focused on how to better predict, prevent and treat disease. In the fall of 2016, Inova and UVA announced a comprehensive research and education partnership to accelerate joint discovery…

Read More

The GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients

Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…

Read More

From Research to Results: Advances in Genitourinary Cancer Treatment  

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile.  This February, I’ll be traveling to…

Read More